TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
242
|
219
|
180 |
| Financial expenses |
0
|
4
|
0 |
| Earnings before taxes |
12
|
8
|
14 |
| EBITDA |
12
|
4
|
14 |
| Total assets |
176
|
190
|
172 |
| Current assets |
164
|
178
|
155 |
| Current liabilities |
33
|
60
|
38 |
| Equity capital |
89
|
77
|
75 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.6%
|
40.5%
|
43.6% |
| Turnover per employee |
121
|
110
|
90 |
| Profit as a percentage of turnover |
5.0%
|
3.7%
|
7.8% |
| Return on assets (ROA) |
6.8%
|
6.3%
|
8.1% |
| Current ratio |
497.0%
|
296.7%
|
407.9% |
| Return on equity (ROE) |
13.5%
|
10.4%
|
18.7% |
| Change turnover |
22
|
54
|
-44 |
| Change turnover % |
10%
|
33%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.